Hemophilia
•
3 likes•1,629 views
Hemophilia is a disorder of the blood clotting system that prevents blood from clotting normally and stopping bleeding. It is caused by deficiencies in certain clotting factors, especially factors VIII and IX. Hemophilia is located on the X chromosome and is predominantly found in males, as they only have one X chromosome. Symptoms include abnormal bleeding and bruising, especially into joints and muscles. There is no cure for hemophilia, but regular injections of the missing clotting factor can control symptoms. Patients must take precautions to prevent injury but are encouraged to exercise and participate in normal activities.
Report
Share
Report
Share
Recommended
Hemophilia
Hemophilia is a genetic disorder that impairs the body's ability to control blood clotting. It is caused by mutations in genes that code for proteins essential for blood clotting. The two main types are hemophilia A, caused by a factor VIII deficiency, and hemophilia B, caused by a factor IX deficiency. Hemophilia is diagnosed through family history, blood tests, and bleeding symptoms that can range from mild bruising to heavy internal bleeding. Treatment focuses on replacing the missing clotting factor through infusions or drugs like desmopressin. Hemophilia affects about 1 in 5,000 male births.
Hemophilia
A ppt about hemophilia, Including a good video. This is about what is hemophilia, why is it there, is it a genetic disorder? What percentage of people get it? Whats the average lifespan now and then?
Hemophilia ppt lakshmi
Hemophilia is an inherited bleeding disorder caused by deficient clotting factors VIII or IX. It is primarily found in males but can be transmitted by female carriers. Hemophilia A is the most common type, accounting for 80-85% of cases and is caused by factor VIII deficiency. Hemophilia B or Christmas disease accounts for 15-20% of cases and results from factor IX deficiency. Diagnosis involves prolonged aPTT and bleeding times as well as low factor VIII or IX levels. Treatment focuses on replacing the missing clotting factor through infusions while also managing pain and preventing injuries.
Hemophilia ppt
This document discusses hemophilia, an inherited bleeding disorder caused by mutations in genes coding for blood clotting factors. It describes the history and genetics of the disease, including that hemophilia is X-linked recessive and mostly affects males. The main types are hemophilia A caused by factor VIII deficiency and hemophilia B caused by factor IX deficiency. Symptoms range from mild to severe bleeding. Treatment involves replacement of the missing clotting factor through therapies like fresh or concentrated plasma.
Heamophilia
Hemophilia is a common hereditary coagulation disorder due to deficiency or reduce activity of clotting factor VIII or clotting factor IX.
This disorder is a X- linked recessive disorder.
Types:
Hemophilia A- deficiency of clotting factors VIII
Hemophilia B- deficiency of clotting factors IX
Hemophilia C- deficiency of clotting factors XI
Parahaemophilia- deficiency of clotting factor V
Causes of hemophilia
Hemophilia has a sex-linked recessive inheritance.
In most cases Hemophilia caused by a mutation in a gene that encodes for one of the clotting factors .
Since the hemophilia gene is located on the X chromosome, Hemophilia usually occurs in males, and Female is the carrier of hemophilia.
Diagnosis
Complete blood cell count
Coagulation studies
FVIII assay
Normal values for FVIII assays are 50-150%. Values in hemophilia are as follows:
Mild: >5%
Moderate: 1-5%
Severe: <1%
Treatment of Hemophilia
Other Types of Treatment
Desmopressin (DDAVP)
Antifibrinolytic Medicines
Vaccinations- hepatitis A and B.
Gene Therapy
Gene Therapy
New Drugs for Hemophilia treatment
New Drugs for Hemophilia treatment
Bangladesh perspectives
Bangladesh would have 10800 hemophiliacs.
But, initially the patients does not concern about hemophilia.
Patients are usually diagnosed only after bleeding episode and sometimes the episode are causes serious consequences.
Conclusion
Primary diagnosis with the success of gene therapy and availability of the new bioengineered products the prospect of the hemophiliacs will be brighter in near future.
Haemophilia
Bleeding for too long? Seek for Help immediately. Blood clotting problem is real and one can be assisted.
Genetics of hemophilia A
The document discusses haemophilia A, which is an X-linked bleeding disorder caused by a deficiency in coagulation factor VIII. It provides details on the genetics and molecular basis of the condition, describing how the factor VIII gene is located on the X chromosome and can be affected by inversions or point mutations. Signs and symptoms involve bleeding episodes in joints, muscles or other tissues. Diagnosis involves testing for prolonged activated partial thromboplastin time and prothrombin time. Treatment relies on regular infusions of replacement factor VIII to control bleeding, though some patients develop inhibitors requiring alternative treatments.
Hemophilia
Hemophilia is a genetic bleeding disorder caused by mutations in genes responsible for blood clotting factors VIII, IX or XI. This leads to prolonged bleeding from cuts or wounds. There are three main types - hemophilia A is the most common type caused by factor VIII deficiency. Hemophilia B or Christmas disease results from factor IX deficiency. Hemophilia C is a rare form caused by factor XI deficiency. Treatment involves replacing the missing clotting factor through infusions to control bleeding. Complications can include joint damage and life-threatening internal bleeding if not properly managed.
Recommended
Hemophilia
Hemophilia is a genetic disorder that impairs the body's ability to control blood clotting. It is caused by mutations in genes that code for proteins essential for blood clotting. The two main types are hemophilia A, caused by a factor VIII deficiency, and hemophilia B, caused by a factor IX deficiency. Hemophilia is diagnosed through family history, blood tests, and bleeding symptoms that can range from mild bruising to heavy internal bleeding. Treatment focuses on replacing the missing clotting factor through infusions or drugs like desmopressin. Hemophilia affects about 1 in 5,000 male births.
Hemophilia
A ppt about hemophilia, Including a good video. This is about what is hemophilia, why is it there, is it a genetic disorder? What percentage of people get it? Whats the average lifespan now and then?
Hemophilia ppt lakshmi
Hemophilia is an inherited bleeding disorder caused by deficient clotting factors VIII or IX. It is primarily found in males but can be transmitted by female carriers. Hemophilia A is the most common type, accounting for 80-85% of cases and is caused by factor VIII deficiency. Hemophilia B or Christmas disease accounts for 15-20% of cases and results from factor IX deficiency. Diagnosis involves prolonged aPTT and bleeding times as well as low factor VIII or IX levels. Treatment focuses on replacing the missing clotting factor through infusions while also managing pain and preventing injuries.
Hemophilia ppt
This document discusses hemophilia, an inherited bleeding disorder caused by mutations in genes coding for blood clotting factors. It describes the history and genetics of the disease, including that hemophilia is X-linked recessive and mostly affects males. The main types are hemophilia A caused by factor VIII deficiency and hemophilia B caused by factor IX deficiency. Symptoms range from mild to severe bleeding. Treatment involves replacement of the missing clotting factor through therapies like fresh or concentrated plasma.
Heamophilia
Hemophilia is a common hereditary coagulation disorder due to deficiency or reduce activity of clotting factor VIII or clotting factor IX.
This disorder is a X- linked recessive disorder.
Types:
Hemophilia A- deficiency of clotting factors VIII
Hemophilia B- deficiency of clotting factors IX
Hemophilia C- deficiency of clotting factors XI
Parahaemophilia- deficiency of clotting factor V
Causes of hemophilia
Hemophilia has a sex-linked recessive inheritance.
In most cases Hemophilia caused by a mutation in a gene that encodes for one of the clotting factors .
Since the hemophilia gene is located on the X chromosome, Hemophilia usually occurs in males, and Female is the carrier of hemophilia.
Diagnosis
Complete blood cell count
Coagulation studies
FVIII assay
Normal values for FVIII assays are 50-150%. Values in hemophilia are as follows:
Mild: >5%
Moderate: 1-5%
Severe: <1%
Treatment of Hemophilia
Other Types of Treatment
Desmopressin (DDAVP)
Antifibrinolytic Medicines
Vaccinations- hepatitis A and B.
Gene Therapy
Gene Therapy
New Drugs for Hemophilia treatment
New Drugs for Hemophilia treatment
Bangladesh perspectives
Bangladesh would have 10800 hemophiliacs.
But, initially the patients does not concern about hemophilia.
Patients are usually diagnosed only after bleeding episode and sometimes the episode are causes serious consequences.
Conclusion
Primary diagnosis with the success of gene therapy and availability of the new bioengineered products the prospect of the hemophiliacs will be brighter in near future.
Haemophilia
Bleeding for too long? Seek for Help immediately. Blood clotting problem is real and one can be assisted.
Genetics of hemophilia A
The document discusses haemophilia A, which is an X-linked bleeding disorder caused by a deficiency in coagulation factor VIII. It provides details on the genetics and molecular basis of the condition, describing how the factor VIII gene is located on the X chromosome and can be affected by inversions or point mutations. Signs and symptoms involve bleeding episodes in joints, muscles or other tissues. Diagnosis involves testing for prolonged activated partial thromboplastin time and prothrombin time. Treatment relies on regular infusions of replacement factor VIII to control bleeding, though some patients develop inhibitors requiring alternative treatments.
Hemophilia
Hemophilia is a genetic bleeding disorder caused by mutations in genes responsible for blood clotting factors VIII, IX or XI. This leads to prolonged bleeding from cuts or wounds. There are three main types - hemophilia A is the most common type caused by factor VIII deficiency. Hemophilia B or Christmas disease results from factor IX deficiency. Hemophilia C is a rare form caused by factor XI deficiency. Treatment involves replacing the missing clotting factor through infusions to control bleeding. Complications can include joint damage and life-threatening internal bleeding if not properly managed.
Sinan abdulhammed hemophilia
Hemophilia is a bleeding disorder caused by an inherited deficiency of coagulation factors, most commonly factor VIII or IX. It is transmitted through females who are carriers but do not have symptoms. There are three main types defined by which clotting factor is deficient. Symptoms include bleeding into joints, muscles, internal organs, and the brain. The severity depends on the level of functioning clotting factor, ranging from severe for levels under 1% to mild for levels of 6-30%. Diagnosis involves family history, measuring clotting factor levels, and prolonged activated partial thromboplastin time. Management focuses on replacing the missing clotting factor through various products or desmopressin. Complications can
Hemophillia
Hemophilia is a hereditary bleeding disorder caused by deficient or defective clotting factors, mainly factor VIII (hemophilia A) and factor IX (hemophilia B). These deficiencies are due to mutations on the X chromosome and thus are X-linked recessive traits. Patients present with bleeding symptoms like hemarthroses, muscle bleeds, or CNS hemorrhages that are out of proportion to any injury. Diagnosis involves identifying prolongation of activated partial thromboplastin time and deficient specific clotting factor levels. Treatment focuses on replacement of the missing clotting factor through infusion of factor concentrates.
Hemophilia Presentation
This document provides an overview of hemophilia, a genetic bleeding disorder caused by a defect in blood clotting factors. It discusses the physical, mental, and emotional characteristics of hemophilia. The genetic source is a defect on the X chromosome, so it primarily affects males. Treatment involves replacing the missing clotting factor through concentrates from donor blood or produced in a lab. Some interesting facts noted are that Queen Victoria passed it to descendants and the life expectancy was previously only 11 years.
Hemophilia
Hemophilia is a genetic bleeding disorder caused by low levels of certain clotting factors in the blood. There are two main types, hemophilia A caused by a factor VIII deficiency and hemophilia B caused by a factor IX deficiency. Symptoms include prolonged bleeding after injuries or surgery. Treatment involves replacing the missing clotting factor through transfusions or injections. Nurses play an important role in managing hemophilia through emotional support, applying pressure to bleeding sites, administering clotting factor treatments, restricting activity after bleeding, and educating patients.
Hemophilia
1. Hemostasis involves vasoconstriction, platelet plug formation, coagulation, and fibrinolysis.
2. Tests like bleeding time, prothrombin time, activated partial thromboplastin time, and thrombin time are used to assess the coagulation pathway.
3. Hemophilia is an inherited bleeding disorder caused by factor VIII or IX deficiency that impairs hemostasis and causes easy bruising and prolonged bleeding.
Heamophilia sumit
This document summarizes the history and treatment of hemophilia. It notes that the Jews were the first to recognize hemophilia and enacted circumcision laws accordingly. Queen Victoria was a carrier whose descendants spread it further. Early treatments involved blood transfusions but storage was not possible. Cryoprecipitate improved treatment in the 1960s while factor concentrates in the 1970s infected many with HIV. Recombinant DNA technology allowed safer treatment from the 1990s onward. Hemophilia is caused by defects on the X chromosome and can be diagnosed through factor level tests. Current research aims to develop gene therapies.
Royal disease
Hemophilia is a genetic bleeding disorder caused by deficiencies in clotting factors, most commonly factors VIII and IX. People with hemophilia can experience both external and internal bleeding, including bleeding into joints and organs. There are three main types of hemophilia - A, B, and C - which differ based on which clotting factor is deficient. Diagnosis involves blood tests and genetic testing. Treatment focuses on replacing the missing clotting factor through infusions of factor concentrates and managing bleeding episodes with RICE therapy.
Haemophilia
Hemophilia is a genetic disorder that impairs the body's ability to control blood clotting. It is caused by a defect in the genes that determine how the body produces clotting factor VIII or IX, which are located on the X chromosome. The main treatment for hemophilia is replacement therapy through slow infusions of concentrated clotting factor VIII or IX to replace the missing or low factors. Other treatments include antifibrinolytic medicines to prevent blood clots from breaking down and desmopressin, a man-made hormone that stimulates the release of stored factor VIII.
Hemophilia,Clinical Presentation, Types,molecular Basis And Inheritance,overv...
Hemophilia,Clinical Presentation, Types,molecular Basis And Inheritance,overv...imam univarsity , college of medicine .
1-Overview of clotting mechanisms.
2-different lab investigation for bleeding disorder.
3-hemophilia, clinical presentation and its types.
4-Molecular basis and inheritance of hemophilia.
5-mechanisims of family and patient pedigree.study of hemophilia
This document summarizes a study on hemophilia. Hemophilia is a genetic bleeding disorder caused by deficiencies in specific clotting factors, resulting in prolonged bleeding. There are two main types: hemophilia A caused by a lack of factor VIII (80% of cases) and hemophilia B caused by a lack of factor IX (20% of cases). A rare third type, hemophilia C, results from a deficiency in factor XI. Hemophilia is inherited and mainly affects males, as the gene is located on the X chromosome. The study examines the genetics and computational approaches to understanding the genes responsible for hemophilia.
Hemophilia
Haemophilia is a rare inherited blood disorder where an essential blood clotting factor is missing or reduced, meaning those affected have difficulty forming blood clots and are prone to excessive bleeding. It occurs in about 1 in 10,000 males and is passed from parent to child. The severity can range from mild to severe depending on the level of the missing clotting factor. While there is no cure, treatment involves replacing the missing clotting factor through injections. Researchers are working on developing gene therapies as a potential long-term treatment.
Hemophilia
Bumps and scrapes that normally cause only minor injuries can be serious for children with hemophilia due to their inability to clot blood properly. Hemophilia is a rare genetic bleeding disorder where the blood is missing or deficient in clotting factor VIII or IX, preventing normal clot formation. While symptoms vary in severity, treatment involves periodic replacement of the missing clotting factor through intravenous infusions to prevent internal bleeding and joint damage, though these treatments are very expensive.
Bio chem presentation on hemophilia
Haemophilia is a bleeding disorder caused by deficiencies in clotting factors VIII or IX. It is inherited through the X chromosome and primarily affects males. Symptoms include prolonged bleeding both internally and externally, especially into joints and muscles. Diagnosis involves measuring factor levels in the blood. Treatment focuses on replacement of the missing clotting factor through medicines or transfusions to prevent or stop bleeding.
Presentation hemophilia corrected
Hemophilia is an inherited bleeding disorder caused by the absence or deficiency of coagulation factor VIII or IX, which are genes located on the X chromosome. There are two main types: hemophilia A caused by a lack of factor VIII and hemophilia B caused by a lack of factor IX. The severity can range from severe, moderate, to minor depending on the level of the deficient clotting factor. Males are most commonly affected since females need two defective X chromosomes to have the disease, though carriers can pass it to their children. There is no cure but effective treatment involves replacing the deficient clotting factor through intravenous administration to reduce bleeding risks.
Hemophilia villaester
Hemophilia is an inherited bleeding disorder caused by deficient or defective clotting factors, predominantly factor VIII and IX. It is passed from mother to son and results in prolonged or excessive bleeding from minor injuries, surgery, or trauma. There are three main types - A, B, and C - based on the specific clotting factor deficiency. Treatment involves replacement of the missing clotting factor through infusions to prevent or stop bleeding episodes. Research continues to develop new treatment options that are more convenient for patients living with this life-long condition.
Hemophilia
Hemophilia is an inherited bleeding disorder caused by mutations in genes responsible for blood clotting factors. It affects males more commonly and is passed through mothers who are carriers. There are two main types - Hemophilia A caused by lack of factor VIII and Hemophilia B caused by lack of factor IX. Diagnosis involves screening and clotting factor tests. Treatment focuses on replacing the deficient clotting factor through transfusions or concentrates to prevent bleeding, though the disease currently has no cure.
Hemophilia
Hemophilia is a genetic bleeding disorder caused by mutations that impair blood clotting abilities. There are three main types (A, B, C) defined by which clotting factor is deficient. Type A is most common, affecting about 1 in 5,000 male births. Symptoms include excessive bleeding from minor injuries, heavy menstrual periods, or bleeding into joints and muscles. Diagnosis involves blood tests to check clotting factor levels and ability to clot. Treatment replaces the missing clotting factor through injections to allow proper clot formation and prevent bleeding complications.
Hemophilia
a powerpoint on hemophilia i needed to make.
**if you want to join an online class if you are interested in history, science, math, english, and other things, join my class!!**
Demands for Haemophilia tratment centres to fullfull universal health access...
Haemophilia ia a rare disease that affect 1: 10 000 people. Demands for services, medication and access to cheap effective clotting factors is a human right for people living with haemophilia. A haemophilia registry is a demand from the Government at large .. Essential drug list should also contain haemophilia medication.
we need to be contacted for more information
www.thinktankent.com
Haemophilia
Follow Atifa Ambreen:
Youtube: https://www.youtube.com/channel/UCVTn-4KeMtXKy1h3_9JbVmw
Facebook: https://www.facebook.com/atifaambreen786/
Instagram: https://www.instagram.com/atifa.ambreen/
https://www.instagram.com/invites/contact/?i=1qo1my1nb2qfx&utm_content=kbo8bi7
Snapchat: https://www.snapchat.com/add/atifa.ambreen
Twitter: https://twitter.com/atifa_ambreen
SUBSCRIBE ...
.
Email for inquiries: atifa.ambreen@gmail.com
Capacity development in animal breeding and genetics—Insights and opportuniti...
Presented by J.M.K. Ojango, B. Malmfors, J. Philipsson, I. Dror and A.M.Okeyo at the Agri4D annual conference on agricultural research for development Uppsala, Sweden, 25−26 September 2013
Blood prac questions
The document provides a list of 40 multiple choice questions about blood and blood components, with options to select whether a given change would cause something to increase, decrease, or stay the same. It then provides an additional 116 multiple choice questions about blood, blood cells, coagulation, hematopoiesis and related processes. The questions cover topics like the components and functions of blood, blood cell types and production sites, coagulation factors and mechanisms, and physiological responses to various conditions.
More Related Content
What's hot
Sinan abdulhammed hemophilia
Hemophilia is a bleeding disorder caused by an inherited deficiency of coagulation factors, most commonly factor VIII or IX. It is transmitted through females who are carriers but do not have symptoms. There are three main types defined by which clotting factor is deficient. Symptoms include bleeding into joints, muscles, internal organs, and the brain. The severity depends on the level of functioning clotting factor, ranging from severe for levels under 1% to mild for levels of 6-30%. Diagnosis involves family history, measuring clotting factor levels, and prolonged activated partial thromboplastin time. Management focuses on replacing the missing clotting factor through various products or desmopressin. Complications can
Hemophillia
Hemophilia is a hereditary bleeding disorder caused by deficient or defective clotting factors, mainly factor VIII (hemophilia A) and factor IX (hemophilia B). These deficiencies are due to mutations on the X chromosome and thus are X-linked recessive traits. Patients present with bleeding symptoms like hemarthroses, muscle bleeds, or CNS hemorrhages that are out of proportion to any injury. Diagnosis involves identifying prolongation of activated partial thromboplastin time and deficient specific clotting factor levels. Treatment focuses on replacement of the missing clotting factor through infusion of factor concentrates.
Hemophilia Presentation
This document provides an overview of hemophilia, a genetic bleeding disorder caused by a defect in blood clotting factors. It discusses the physical, mental, and emotional characteristics of hemophilia. The genetic source is a defect on the X chromosome, so it primarily affects males. Treatment involves replacing the missing clotting factor through concentrates from donor blood or produced in a lab. Some interesting facts noted are that Queen Victoria passed it to descendants and the life expectancy was previously only 11 years.
Hemophilia
Hemophilia is a genetic bleeding disorder caused by low levels of certain clotting factors in the blood. There are two main types, hemophilia A caused by a factor VIII deficiency and hemophilia B caused by a factor IX deficiency. Symptoms include prolonged bleeding after injuries or surgery. Treatment involves replacing the missing clotting factor through transfusions or injections. Nurses play an important role in managing hemophilia through emotional support, applying pressure to bleeding sites, administering clotting factor treatments, restricting activity after bleeding, and educating patients.
Hemophilia
1. Hemostasis involves vasoconstriction, platelet plug formation, coagulation, and fibrinolysis.
2. Tests like bleeding time, prothrombin time, activated partial thromboplastin time, and thrombin time are used to assess the coagulation pathway.
3. Hemophilia is an inherited bleeding disorder caused by factor VIII or IX deficiency that impairs hemostasis and causes easy bruising and prolonged bleeding.
Heamophilia sumit
This document summarizes the history and treatment of hemophilia. It notes that the Jews were the first to recognize hemophilia and enacted circumcision laws accordingly. Queen Victoria was a carrier whose descendants spread it further. Early treatments involved blood transfusions but storage was not possible. Cryoprecipitate improved treatment in the 1960s while factor concentrates in the 1970s infected many with HIV. Recombinant DNA technology allowed safer treatment from the 1990s onward. Hemophilia is caused by defects on the X chromosome and can be diagnosed through factor level tests. Current research aims to develop gene therapies.
Royal disease
Hemophilia is a genetic bleeding disorder caused by deficiencies in clotting factors, most commonly factors VIII and IX. People with hemophilia can experience both external and internal bleeding, including bleeding into joints and organs. There are three main types of hemophilia - A, B, and C - which differ based on which clotting factor is deficient. Diagnosis involves blood tests and genetic testing. Treatment focuses on replacing the missing clotting factor through infusions of factor concentrates and managing bleeding episodes with RICE therapy.
Haemophilia
Hemophilia is a genetic disorder that impairs the body's ability to control blood clotting. It is caused by a defect in the genes that determine how the body produces clotting factor VIII or IX, which are located on the X chromosome. The main treatment for hemophilia is replacement therapy through slow infusions of concentrated clotting factor VIII or IX to replace the missing or low factors. Other treatments include antifibrinolytic medicines to prevent blood clots from breaking down and desmopressin, a man-made hormone that stimulates the release of stored factor VIII.
Hemophilia,Clinical Presentation, Types,molecular Basis And Inheritance,overv...
Hemophilia,Clinical Presentation, Types,molecular Basis And Inheritance,overv...imam univarsity , college of medicine .
1-Overview of clotting mechanisms.
2-different lab investigation for bleeding disorder.
3-hemophilia, clinical presentation and its types.
4-Molecular basis and inheritance of hemophilia.
5-mechanisims of family and patient pedigree.study of hemophilia
This document summarizes a study on hemophilia. Hemophilia is a genetic bleeding disorder caused by deficiencies in specific clotting factors, resulting in prolonged bleeding. There are two main types: hemophilia A caused by a lack of factor VIII (80% of cases) and hemophilia B caused by a lack of factor IX (20% of cases). A rare third type, hemophilia C, results from a deficiency in factor XI. Hemophilia is inherited and mainly affects males, as the gene is located on the X chromosome. The study examines the genetics and computational approaches to understanding the genes responsible for hemophilia.
Hemophilia
Haemophilia is a rare inherited blood disorder where an essential blood clotting factor is missing or reduced, meaning those affected have difficulty forming blood clots and are prone to excessive bleeding. It occurs in about 1 in 10,000 males and is passed from parent to child. The severity can range from mild to severe depending on the level of the missing clotting factor. While there is no cure, treatment involves replacing the missing clotting factor through injections. Researchers are working on developing gene therapies as a potential long-term treatment.
Hemophilia
Bumps and scrapes that normally cause only minor injuries can be serious for children with hemophilia due to their inability to clot blood properly. Hemophilia is a rare genetic bleeding disorder where the blood is missing or deficient in clotting factor VIII or IX, preventing normal clot formation. While symptoms vary in severity, treatment involves periodic replacement of the missing clotting factor through intravenous infusions to prevent internal bleeding and joint damage, though these treatments are very expensive.
Bio chem presentation on hemophilia
Haemophilia is a bleeding disorder caused by deficiencies in clotting factors VIII or IX. It is inherited through the X chromosome and primarily affects males. Symptoms include prolonged bleeding both internally and externally, especially into joints and muscles. Diagnosis involves measuring factor levels in the blood. Treatment focuses on replacement of the missing clotting factor through medicines or transfusions to prevent or stop bleeding.
Presentation hemophilia corrected
Hemophilia is an inherited bleeding disorder caused by the absence or deficiency of coagulation factor VIII or IX, which are genes located on the X chromosome. There are two main types: hemophilia A caused by a lack of factor VIII and hemophilia B caused by a lack of factor IX. The severity can range from severe, moderate, to minor depending on the level of the deficient clotting factor. Males are most commonly affected since females need two defective X chromosomes to have the disease, though carriers can pass it to their children. There is no cure but effective treatment involves replacing the deficient clotting factor through intravenous administration to reduce bleeding risks.
Hemophilia villaester
Hemophilia is an inherited bleeding disorder caused by deficient or defective clotting factors, predominantly factor VIII and IX. It is passed from mother to son and results in prolonged or excessive bleeding from minor injuries, surgery, or trauma. There are three main types - A, B, and C - based on the specific clotting factor deficiency. Treatment involves replacement of the missing clotting factor through infusions to prevent or stop bleeding episodes. Research continues to develop new treatment options that are more convenient for patients living with this life-long condition.
Hemophilia
Hemophilia is an inherited bleeding disorder caused by mutations in genes responsible for blood clotting factors. It affects males more commonly and is passed through mothers who are carriers. There are two main types - Hemophilia A caused by lack of factor VIII and Hemophilia B caused by lack of factor IX. Diagnosis involves screening and clotting factor tests. Treatment focuses on replacing the deficient clotting factor through transfusions or concentrates to prevent bleeding, though the disease currently has no cure.
Hemophilia
Hemophilia is a genetic bleeding disorder caused by mutations that impair blood clotting abilities. There are three main types (A, B, C) defined by which clotting factor is deficient. Type A is most common, affecting about 1 in 5,000 male births. Symptoms include excessive bleeding from minor injuries, heavy menstrual periods, or bleeding into joints and muscles. Diagnosis involves blood tests to check clotting factor levels and ability to clot. Treatment replaces the missing clotting factor through injections to allow proper clot formation and prevent bleeding complications.
Hemophilia
a powerpoint on hemophilia i needed to make.
**if you want to join an online class if you are interested in history, science, math, english, and other things, join my class!!**
Demands for Haemophilia tratment centres to fullfull universal health access...
Haemophilia ia a rare disease that affect 1: 10 000 people. Demands for services, medication and access to cheap effective clotting factors is a human right for people living with haemophilia. A haemophilia registry is a demand from the Government at large .. Essential drug list should also contain haemophilia medication.
we need to be contacted for more information
www.thinktankent.com
Haemophilia
Follow Atifa Ambreen:
Youtube: https://www.youtube.com/channel/UCVTn-4KeMtXKy1h3_9JbVmw
Facebook: https://www.facebook.com/atifaambreen786/
Instagram: https://www.instagram.com/atifa.ambreen/
https://www.instagram.com/invites/contact/?i=1qo1my1nb2qfx&utm_content=kbo8bi7
Snapchat: https://www.snapchat.com/add/atifa.ambreen
Twitter: https://twitter.com/atifa_ambreen
SUBSCRIBE ...
.
Email for inquiries: atifa.ambreen@gmail.com
What's hot (20)
Hemophilia,Clinical Presentation, Types,molecular Basis And Inheritance,overv...
Hemophilia,Clinical Presentation, Types,molecular Basis And Inheritance,overv...
Demands for Haemophilia tratment centres to fullfull universal health access...
Demands for Haemophilia tratment centres to fullfull universal health access...
Viewers also liked
Capacity development in animal breeding and genetics—Insights and opportuniti...
Presented by J.M.K. Ojango, B. Malmfors, J. Philipsson, I. Dror and A.M.Okeyo at the Agri4D annual conference on agricultural research for development Uppsala, Sweden, 25−26 September 2013
Blood prac questions
The document provides a list of 40 multiple choice questions about blood and blood components, with options to select whether a given change would cause something to increase, decrease, or stay the same. It then provides an additional 116 multiple choice questions about blood, blood cells, coagulation, hematopoiesis and related processes. The questions cover topics like the components and functions of blood, blood cell types and production sites, coagulation factors and mechanisms, and physiological responses to various conditions.
Josh Stephens 8 Y Hens
1) The farmer observed the egg production of her chickens and wants to breed chickens to produce "super hens" that lay many large eggs.
2) She notes the number and size of eggs laid by each of her chickens: Marjory lays 5 small eggs per week, Rosemary lays 10 small eggs per week, Brian lays 6 large eggs per week, and Bob lays 8 small eggs per week.
3) Through selective breeding over multiple generations, pairing chickens with desirable traits, the farmer is able to produce offspring that consistently lay many large eggs, achieving her goal of "super hens".
Harri Evans 8 Y Hens
The document discusses selecting chickens and cockerels for breeding to produce chickens that lay many large eggs. It describes two chickens, Rosemary and Brian, being considered for breeding based on the sizes and numbers of eggs they currently lay. The goal is to use selective breeding over multiple generations to develop a "super hen" capable of maximally high egg production.
Different types of blood cells
This document describes the different types of blood cells. It discusses red blood cells which help transport gases and have a lifespan of 120 days. It also outlines the various white blood cells - lymphocytes, monocytes, eosinophils, basophils, and neutrophils - and their distinguishing nuclear shapes. Finally, it mentions platelets which lack a nucleus and help with blood clotting.
PPT on blood
Blood is a complex fluid connective tissue that transports cells and substances throughout the body. It is composed of plasma and formed elements like red blood cells, white blood cells, and blood platelets. Plasma is the liquid portion that makes up 55% of blood volume and transports nutrients. Red blood cells contain hemoglobin and carry oxygen from the lungs to tissues and carbon dioxide back to the lungs. White blood cells help fight infections. Blood platelets initiate blood clotting.
Blood Clot formation
Blood clots are clumps of blood that form when blood hardens from a liquid to a solid. They can occur in deep veins, lungs, or brain and cause symptoms like swelling, pain, and skin discoloration. Blood clots form due to inactivity, surgery, pregnancy, dehydration, birth control, smoking, obesity, or genetic disorders. They are detected through tests like venography, ultrasound, MRI, and CT scans. Treatment involves medication, and prevention focuses on staying active and hydrated. Blood clots can block arteries or veins and affect the heart, intestines, kidneys, legs, lungs, neck or brain.
Approach To The Management Of Hyperbilirubinemia In Term
This document provides guidelines for the management of hyperbilirubinemia, or high bilirubin levels, in term newborn infants. It discusses the definition and causes of both physiologic and pathologic jaundice. Guidelines are given for prevention, screening, treatment with phototherapy or exchange transfusion, and identifying infants at risk of developing severe hyperbilirubinemia or kernicterus. Risk factors include jaundice in the first 24 hours or visible jaundice at discharge. Close follow-up is recommended for infants with risk factors.
Presentation1
The document summarizes the structure and function of skin, the process of wound healing, and factors that can affect wound healing. It discusses the following key points:
- Skin is composed of several layers including the epidermis, dermis, and subcutaneous layer. Its structure varies depending on its location on the body.
- Wound healing involves regeneration of epithelial tissue and formation of connective scar tissue. It occurs through the phases of inflammation, proliferation, and remodeling.
- The three classifications of wound healing are primary intention, secondary intention, and delayed primary healing. Primary intention healing results in minimal scarring.
- The phases of wound healing involve coagulation, inflammation, proliferation, epithelialization
Umesh
Molecular genetics plays an important role in medicine by allowing the study of inherited diseases, mapping disease genes, analyzing how genes cause disease, and diagnosing and treating genetic conditions. DNA isolation is the process of extracting DNA from a source, such as whole blood, cultured cells, or tissues, and separating it from other cellular components. Isolation methods involve lysing cells, removing proteins and contaminants, and recovering purified DNA. The choice of isolation method depends on factors like the DNA quantity and purity needed for downstream applications. DNA purification further separates DNA from other molecules and evaluates the extracted DNA.
Ultrafiltration
Ultrafiltration is the process of removing water from the bloodstream during hemodialysis to achieve solute clearance and adequate fluid removal. There are two main methods of controlling ultrafiltration: pressure control, where blood compartment pressure is increased to remove fluid, and volumetric control, which directly measures ultrafiltrate volume for more accurate control. High efficiency dialysis aims for high urea and solute clearance rates using large surface area membranes and optimized blood and dialysate flows. High flux dialysis uses more permeable membranes to improve clearance of middle and large molecules. Hemofiltration provides solute clearance solely through convection while hemodiafiltration combines dialysis with large volume ultrafiltration for combined con
Genetics of animal breeding 9
This document discusses genetics and animal breeding. It explains how genetics relates to livestock improvement and describes cell division, inheritance of traits, and genetic principles like dominance, sex determination, linkage and mutation. Additive gene effects from many genes cumulatively influence economically important quantitative traits like growth and milk production, while non-additive genes control fewer qualitative traits. Heritability estimates the proportion of variation due to genetics. Selection of superior breeding stock relies on performance records and expected progeny differences to make genetic progress over generations.
Hemostasis principles
This document provides an overview of principles of hemostasis. It begins with an introduction and discusses Virchow's triad, which describes the three main factors that influence blood coagulation: changes in blood vessels, blood flow, and blood components. Primary hemostasis mediated by platelets is described. Secondary hemostasis and the coagulation cascade are then explained. Laboratory tests for evaluating hemostasis are also summarized. The document concludes with sections on vitamin K antagonists and the anticoagulant warfarin.
Blood clotting - AS OCR F221
The document summarizes how blood clots form to stop bleeding from damaged blood vessels. When tissue is damaged, platelets stick to exposed collagen fibers and release substances that allow them to clump together, forming an initial plug. Thromboplastin is released and activates prothrombin into thrombin, which converts fibrinogen into fibrin fibers that form a mesh trapping blood cells into a clot. The clot then dries to form a scab that prevents further blood loss and pathogen entry into the wound.
Blood clotting
The clotting process begins when blood vessels are damaged. Platelets are released from the bloodstream and stick to the damaged tissue, where they release enzymes that trigger a chain reaction. This leads to the conversion of fibrinogen into fibrin threads, which weave together to form a blood clot that seals the break in the blood vessel. For patients with hemophilia, this clotting process does not work properly due to a genetic defect, so their blood does not clot normally and they are at risk of excessive bleeding from minor injuries. The document then describes the steps of clotting in more detail and discusses some blood clotting disorders.
Ultrafiltration
This document discusses ultra filtration, including:
- Ultra filtration uses membranes with pore sizes between 0.1-0.001 microns to separate high molecular-weight substances, colloids, and polymers from water.
- It works by filtering influent water against the membrane wall, retaining particles, microbes, and turbidity inside while permeate passes through.
- Key factors that affect ultra filtration performance are pore size, membrane type, flow across the membrane surface, operating pressure, and operating temperature.
Coagulation tests
The bleeding time test measures the time it takes for a small puncture wound to stop bleeding. It evaluates platelet function and vascular integrity. The preferred method is the Surgicutt/Simplate method, which uses a spring-loaded device to make a standardized 1mm deep incision. The procedure involves inflating a blood pressure cuff to 40mmHg, making the incision, and blotting the wound every 30 seconds with filter paper to see when bleeding stops. The normal bleeding time range is 1-9 minutes. Sources of error include aspirin use, improper puncture technique, not timing correctly, or allowing the filter paper to touch the wound.
blood clotting
seminar about blood clotting by Hina Yaseen Ranjha from Sargodha Pakistan...further can contact at zoology450@gmail.com
Blood clotting
Blood clotting is a process called coagulation where blood changes from a liquid to a solid gel-like state. It occurs through a cascade of biochemical reactions involving multiple clotting factors. Initially fibrinogen is converted to fibrin, which forms a mesh that entangles blood cells. Then the clot undergoes further changes to strengthen it. Precise regulation of coagulation prevents clotting inside healthy blood vessels but allows it to occur when vessels are damaged.
Blood Clotting Mechanism
The document summarizes the blood clotting (coagulation) mechanism. It occurs when blood is shed from damaged blood vessels or tissues. There are two pathways - the extrinsic pathway which is initiated by tissue factor, and the intrinsic pathway initiated by platelets. Both pathways involve a cascade of coagulation factors and ultimately lead to the formation of a prothrombinase complex. This converts prothrombin to thrombin via the common pathway. Thrombin then converts fibrinogen to fibrin to form a mesh and stabilize the platelet plug, sealing the break in the blood vessel.
Viewers also liked (20)
Capacity development in animal breeding and genetics—Insights and opportuniti...
Capacity development in animal breeding and genetics—Insights and opportuniti...
Approach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In Term
Similar to Hemophilia
Hemophilia
Hemophilia is a hereditary bleeding disorder caused by a deficiency of specific clotting factors, which prevents normal blood clotting. The two main types are hemophilia A caused by a factor VIII deficiency and hemophilia B caused by a factor IX deficiency. Symptoms include excessive bleeding, easy bruising, and bleeding into joints. It is usually passed from mother to son and is treated through replacement of the deficient clotting factor. Nursing care focuses on prevention of injury, control of bleeding episodes, and prevention of joint damage.
Hemophilia PPT 4th period.pptx
Hemophilia is a genetic blood disorder caused by mutations in the F8 or F9 genes responsible for blood clotting factors VIII and IX. These mutations result in reduced or defective clotting factors, preventing blood from clotting properly. Common symptoms include easy bruising, bleeding gums, excessive bleeding from minor cuts or injuries, and joint bleeding that can lead to chronic joint damage. Hemophilia is diagnosed through screening tests that detect clotting abnormalities and clotting factor assays that identify the specific factor deficiency. Current treatment focuses on replacement therapy through injections of the missing clotting factor to control bleeding and prevent complications.
Student Work Hemophilia
Hemophilia is a genetic bleeding disorder caused by a defect in the genes responsible for blood clotting factors VIII or IX. It is usually inherited and affects boys more than girls. Symptoms include prolonged bleeding after injuries or medical procedures. Treatment involves replacing the missing clotting factor through infusions of donated blood products. Current research is developing new formulations of clotting factors that can be stored at room temperature to improve accessibility.
genetic basis of hemophilia
Hemophilia is a genetic disorder that impairs the body's ability to control blood clotting. It is caused by insufficient or defective clotting factors, which are proteins in blood that control bleeding. Hemophilia is usually inherited in an X-linked recessive pattern and is more common in males than females. Treatment involves replacing the missing clotting factor to prevent excessive bleeding.
haemophilia-170526085552 (1).pdf
Hemophilia is a hereditary bleeding disorder caused by deficient or defective clotting factors, mainly factor VIII (hemophilia A) and factor IX (hemophilia B). It is transmitted through females to males via an X-linked recessive pattern. Symptoms include prolonged bleeding after injury and spontaneous bleeding in joints/muscles. Diagnosis involves measuring clotting factor levels. Management focuses on preventing bleeding episodes through factor replacement therapy, gene therapy, desmopressin, and other treatments like cryoprecipitate and fibrin glue. Hemophilia was first documented in the 2nd century AD and is known as the "royal disease" due to its prevalence among European royalty.
Hemophilia
Hemophilia is an inherited bleeding disorder caused by deficient or defective clotting factors. There are three main types - Hemophilia A caused by Factor VIII deficiency, Hemophilia B caused by Factor IX deficiency, and Hemophilia C caused by Factor XI deficiency. Hemophilia A accounts for about 98% of cases and is X-linked recessive inherited. Symptoms range from easy bruising to spontaneous internal bleeding. Diagnosis involves blood tests of clotting factors and family history. Treatment focuses on replacement of missing clotting factors through infusion or preventing bleeding through antifibrinolytic drugs.
Hemophilia
This document provides information about hemophilia, including:
- Hemophilia is an inherited bleeding disorder caused by deficiencies in specific clotting factors like VIII or IX.
- There are three main types - A, B, and C - determined by which clotting factor is deficient.
- It is passed from parents to children via genes on the X chromosome.
- Symptoms include bruising and bleeding, especially into joints or muscles. Treatment aims to prevent bleeding complications through blood transfusions or replacement of the deficient clotting factor.
Bleeding , Coagulation.pptx
Disorders of blood... excessive bleeding disroders and coagulopathies and the mechanism behind these are all discussed in this
Hemophilia
Hemophilia is a bleeding disorder that slows down the blood clotting process. People who have hemophilia often have longer bleeding after an injury or surgery. People who have severe hemophilia have spontaneous bleeding into the joints and muscles. Hemophilia occurs more commonly in males than in females.The two most common types of hemophilia are hemophilia A (also known as classic hemophilia) and hemophilia B (also known as Christmas disease). People who have hemophilia A have low levels of a blood clotting factor called factor eight (FVIII). People who have hemophilia B have low levels of factor nine (FIX).
The two types of hemophilia are caused by permanent gene changes (mutations) in different genes. Mutations in the FVIII gene cause hemophilia A. Mutations in the FIX gene cause hemophilia B. Proteins made by these genes have an important role in the blood clotting process. Mutations in either gene keep clots from forming when there is an injury, causing too much bleeding that can be difficult to stop
Hemophilia A is the most common type of this condition. One in 5,000 to 10,000 males worldwide have hemophilia A. Hemophilia B is less common, and it affects 1 in 20,000 to 34,500 males worldwide.
hemophilia blood disorder hemophilia.pptx
Hemophilia is a hereditary bleeding disorder caused by deficiencies in clotting factors VIII or IX. The most common symptoms are heavy, uncontrollable bleeding from minor injuries or spontaneously in joints or muscles. There are three main types - Hemophilia A caused by factor VIII deficiency is most common, Hemophilia B caused by factor IX deficiency, and Hemophilia C caused by factor XI deficiency. Treatment focuses on replacement of the missing clotting factor through transfusions or medication to prevent or stop bleeding episodes.
Hemophilia
Hemophilia is a genetic bleeding disorder that impairs the body's ability to form blood clots. It is caused by defects in the genes responsible for blood clotting factors VIII or IX, and is inherited through the X chromosome. The main symptoms are prolonged bleeding from minor injuries, easy bruising, and bleeding into joints or muscles. Treatment involves replacing the missing clotting factor through infusions of factor concentrates. With effective treatment, people with hemophilia can live normal lifespans, though they remain at risk for joint damage from repeated bleeding. Carriers can have children with hemophilia, with risks varying based on the genetic status of both parents.
Genetic disorders
Hemophilia is a bleeding disorder caused by mutations in the F8 or F9 genes that produce coagulation factors essential for blood clotting. This results in prolonged or excessive bleeding from minor injuries. The two main types are hemophilia A (F8 gene) and B (F9 gene). It is inherited in an X-linked recessive pattern and mainly affects males. Symptoms can range from mild to severe bleeding depending on the level of coagulation factor present.
haemophilia.pptx
Hemophilia is a hereditary bleeding disorder caused by deficiencies in clotting factors VIII or IX. It is transmitted through females to males and results in longer bleeding times after injuries or spontaneous bleeding in joints and muscles. Diagnosis involves measuring clotting factor levels, with types A and B defined by deficiencies in factors VIII and IX respectively. Management focuses on preventing bleeding episodes through local measures, replacement therapy using concentrates of missing clotting factors, and drugs like desmopressin that stimulate factor release.
Hemophila pp
Hemophilia is a genetic bleeding disorder caused by mutations on the F8 gene located on the X chromosome. People with hemophilia experience prolonged bleeding from minor injuries due to a lack of clotting factor VIII or IX in their blood. Treatment involves replacement therapy through frequent injections of clotting factor concentrates. While treatment allows people with hemophilia to live normal lives, risks include developing antibodies against the clotting factor and bleeding complications. Researchers are studying gene therapy as a potential cure by correcting the defective genes that cause hemophilia.
Essay On Sickle Cell Anemia
The document provides information about sickle cell anemia. It discusses that sickle cell anemia is a genetic blood disorder where red blood cells become sickle shaped and have trouble flowing through small blood vessels. This causes tissue damage from lack of blood flow. Symptoms include anemia, pain episodes, organ damage, and stroke. It is inherited when both parents carry the sickle cell gene. While there is no cure, treatment focuses on managing pain and preventing complications.
Hemophilia
Hemophilia A is an inherited blood disorder where the blood does not clot normally due to a lack of clotting factor VIII. Symptoms include spontaneous bleeding, bruising, joint pain and swelling, and internal bleeding. The disease is passed down from mothers to sons on the X chromosome. Treatment involves replacing the missing clotting factor through intravenous injections or nasal spray medication. There is no cure for hemophilia, but genetic counseling can help determine risk for children.
Genetic Disorder
This slide is made for my university assignment.Here I describe type of genetic disorder and described haemophilia.
Hemophilia
Hemophilia is a rare inherited blood clotting disorder caused by deficient blood proteins. It is passed down from mother to son through genes on the X chromosome. Symptoms include prolonged bleeding from cuts or wounds and internal bleeding in joints that can lead to arthritis if untreated. Physicians test for hemophilia by ruling out other disorders and determining which clotting factor is deficient. About 1 in 4,000 males have the disorder. Treatment involves regularly injecting purified clotting factors to prevent or stop bleeding episodes.
Chapter 4 genetic disorders
Genetic disorders can be caused by mutations present during meiosis or in a parent's cells, or changes in a person's DNA. Three examples of genetic disorders discussed are cystic fibrosis, sickle-cell disease, and hemophilia. Cystic fibrosis causes thick mucus buildup in the lungs and intestines, making breathing and digestion difficult. Sickle-cell disease affects red blood cells, causing them to become misshapen and unable to carry oxygen effectively. Hemophilia is a disorder where blood clots slowly or not at all.
Similar to Hemophilia (19)
Recently uploaded
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
Biological Screening of Herbal Drugs in detailed.
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
How to Build a Module in Odoo 17 Using the Scaffold Method
Odoo provides an option for creating a module by using a single line command. By using this command the user can make a whole structure of a module. It is very easy for a beginner to make a module. There is no need to make each file manually. This slide will show how to create a module using the scaffold method.
How to Manage Your Lost Opportunities in Odoo 17 CRM
Odoo 17 CRM allows us to track why we lose sales opportunities with "Lost Reasons." This helps analyze our sales process and identify areas for improvement. Here's how to configure lost reasons in Odoo 17 CRM
What is the purpose of studying mathematics.pptx
Students often ask about what the purpose is for their learning. This PowerPoint highlights some really important reasons to study Mathematics.
A Strategic Approach: GenAI in Education
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective UpskillingExcellence Foundation for South Sudan
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.Top five deadliest dog breeds in America
Thinking of getting a dog? Be aware that breeds like Pit Bulls, Rottweilers, and German Shepherds can be loyal and dangerous. Proper training and socialization are crucial to preventing aggressive behaviors. Ensure safety by understanding their needs and always supervising interactions. Stay safe, and enjoy your furry friends!
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxMohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance
Thesis Statement for students diagnonsed withADHD.ppt
Presentation required for the master in Education.
Recently uploaded (20)
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
Film vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movie
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRM
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
Hemophilia
- 1. Hemophilia Hemophilia is a disorder to your blood-clotting system. Clotting is the process by which your blood changes from a liquid to a solid state in order to stop bleeding.
- 2. History and Background The word hemo comes from the Latin which means “blood”. The word philia also comes from Latin which means “friendship” The earliest recorded documentation was found in A.D. in the Jewish religious of circumcision. Hemophilia was also found in the youngest son of Great Britain's Queen Victoria his name is Prince Leopold
- 3. Symptoms Symptoms are primary abnormal bleeding & bruises. Joint pain, swelling from internal bleeding. Tightness in joints Painful headaches Neck pain In toddlers, simply by falling can cause bruising and bleeding. In teens & adults bleeding may involve muscles, joints that can hinder movement.
- 4. Type of inheritance The human blood contains 13 clotting factor. Deficiencies of factors VII, IX . This disorder is located on X chromosome. This makes this a sex-linked disorder. Since men have only one X chromosome, so if men inherit this disease it will because they get the X chromosome from their mother.
- 6. What chromosome & Who gets it It is on the X-chromosome. A gender sex-linked disorder. Predominantly males however in some severe cases females can get it, too.
- 7. Culture, Race, and Religion Jewish males. In European countries.
- 8. Treatment and Cures For hemophilia A and B they regularly inject themselves with a blood clotting factor that comes from powder mixed with sterile water. The powder contains plasma that is freeze dried. Hemophilia has no cures.
- 9. Living with Hemophilia One thing that parents have learned is not to be over protective. If this happens there kids become isolated from other kids. Kids with hemophilia should be encouraged to exercise and participate in sports. To do this they must take precautions, wearing a helmet, wearing nee or elbow pads, and using common sense.
- 11. Bibliography The mayoclinic.com/health/hemophilia date found on 2/4/09 www.bioedonline.org/slides/slide01.cfm 2/5/09 Book Diseases and people Hemophilia Copyright 2001 by Edward Willett Library of Congress Cataloging –in-publication Date Willett, Edward, 1959 pg.32,33,35,51,52,55,76,77,78